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a b s t r a c t
A liquid nitrogen jet-cooled thermal modulator dedicated to comprehensive two-dimensional gas chro-
matography has been mounted in a GC oven coupled to a high resolution magnetic sector mass
spectrometry instrument. The data acquisition parameters of the slow double-focusing magnetic sec-
tor MS instrument have been optimized to accommodate the description of the narrow modulated
GC peaks. Acquisition rates were increased to 20Hz, while maintaining high mass resolution. Selected
ion monitoring (SIM) descriptors, typically including several ions for both native and labeled analytes,
were thus reduced to one or two to ensure enough MS cycle time. For maximization of the sensitivity
enhancement due to cryogenic zone compression (CZC), the entire GC peak of interest was trapped and
remobilized in one event. Optimization of the method resulted in the ability to detect low attogram
(ag) amounts of 2,3,7,8-tetrachlorodibenzo-p-dioxin (2,3,7,8-TCDD) (313ag gives a S/N of 400:1), a level
that had not yet been attained using classical GC–HRMS. An isotope-dilution calibration curve was con-
structed using 13C12-2,3,7,8-TCDD as the internal standard over the range of 500ag/L to 35,000ag/L
(R2 = 0.9953). Analyses of a standard natural human reference serum-matrix NIST SRM 1589a containing
223ag of 1,2,3,7,8-pentachlorodibenzo-p-dioxin (1,2,3,7,8-PeCDD) (70% recovery rate assumed) resulted
in a peak with a S/N of 188:1 (4 sigma, m/z=355.8546). Measurement of 2,2-bis (4-chlorophenyl-1,1,1-
trichloroethane) (DDE) and 2,2′,4,4′,5,5′-hexabromobiphenyl (BB-153) in human dried-blood spot (DBS)
samples is also reported to illustrate the usefulness of such a sensitive technique. Finally, some of the
challenges related to sample preparation, blank levels, and to the fact of measuring of such a limited
number of molecules (less than 600,000 TCDD molecules) are discussed.
© 2010 Elsevier B.V. All rights reserved.
1. Introduction
For the last 25 years, background levels of polychlori-
nated dibenzo-p-dioxins (PCDDs), polychlorinated dibenzofurans
(PCDFs), polychlorinated biphenyls (PCBs), and related persistent
organic pollutants (POPs) in humans have declined to the point that
their measurement has become increasingly difficult [1]. Improv-
ing sample preparation procedures to accommodate larger sample
sizes has been carried out to a certain extent at the beginning of
the last decade but these methods became of limited use because
of the increasing demand to reduce the size of the specimen
collected for human biomonitoring. Additionally, moving from
∗ Corresponding author. Tel.: +1 706 253 4666.
E-mail address: donpatt@etcmail.com (D.G. Patterson Jr.).
an invasive adipose tissue collection to a more readily available
blood (serum) matrix also contributed to reducing the quantity
of the lipophilic toxicants available for measurement due to the
reduced lipid content of serum. From an analytical point of view,
gas chromatography (GC) coupled to magnetic sector high resolu-
tion mass spectrometry (HRMS) is the most sensitive and specific
technique in the field of ultra-trace measurement of halogenated
toxicants. Theuseof isotopedilution (ID)basedon13C-labeled stan-
dards at a minimum mass resolution of 10,000 resolving power
in the selected ion monitoring (SIM) acquisition mode, ensures
enhanced selectivity and the lowest attainable sensitivity [2]. How-
ever, for the reasons listed above, more and more compounds
are present at levels below the limits of detection (LODs) estab-
lished using quality assurance/quality control (QA/QC) criteria. The
analysis of data sets that include non-detectable values is a diffi-
cult task because several approaches are available and different
0021-9673/$ – see front matter © 2010 Elsevier B.V. All rights reserved.
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approaches might lead to significantly different observations in
environmental research [3]. Therefore, increasing the sensitivity of
the state-of-the-art GC–IDHRMS measurement method is an area
of considerable interest not only for analysts to report valuable
congener-specific data but also for toxicologist who need a full pic-
ture to assess human exposure and the health impacts of these
POPs.
The concept of thermal modulation in gas chromatography first
appeared 25 years ago when Phillips and co-workers reported
on ‘Multiplex Gas Chromatography’ [4]. The idea went forward
and is now called ‘comprehensive two-dimensional gas chro-
matography’ (GC×GC), which is a hyphenated approach offering
additional dimensionality over classical GC [5]. The major advan-
tage of the technique is its capability to increase the peak
capacity of the chromatographic separation which can be as
high as the product of the peak capacities of the two individ-
ual columns that are made of orthogonal GC stationary phases
[6]. GC×GC is therefore increasingly used when complex mix-
tures of compounds have to be separated such as in the case
of petroleum analysis [7], flavour and fragrance characterisa-
tion [8], forensic investigations [9], environmental measurements
[10], food control [11], and human biomonitoring [12]. Another
breakthrough benefit of GC×GC is that the detectability limit
can be up to 2–20 times better than single dimensional GC
due to the signal-to-noise ratio enhancement related to thermal
modulation [13–19]. Therefore, modulators can also have some
potential applications as signal enhancers, as well as peak capacity
enhancers.
In the early days of the GC×GC technique, two-stage ther-
mal desorption modulators (TDM) consisted of fragile GC capillary
columns carefully coveredby electrically conductive paint towhich
electrical current pulses were applied at constant time interval
[20]. Since then, efforts have been dedicated to the production of
more robust non-moving modulators capable of performing with
no excessive downtime. Among the different ones, gas jet based
thermal modulators appeared to be the most efficient. A previ-
ous report describes the use of a quad-jet modulator installed on
a GC coupled to a time-of-flight (TOF) MS for both peak capacity
and signal enhancement in the isotope-dilution measurement of
59 selected POPs in human serum and milk [12]. Quadruple- and
dual-jet configuration systems [21,22] later evolved into a sim-
ple, rugged, and reliable device named the loop modulator [23].
This jet-cooled modulator consists of one cold and one hot jet
mounted perpendicular to each other. The dual stage modula-
tion is achieved by looping the modulation tube so that it passes
twice in the cold jet path. Remobilization of the cryo-trapped com-
pounds occurs on both spots simultaneously when the hot jet is
fired.
In the mid 1990s, because it was already expected that ther-
malmodulation coupledwith amagnetic sectormass spectrometer
would result in an instrument offering the ultimate attainable sen-
sitivity for measurement of these compounds, scientists at the
Centers for Disease Control and prevention (CDC) attempted the
coupling of GC×GC to HRMS for the measurement of PCDD/Fs
and related contaminants in human serum [24,25]. Promising data
were produced at the attogram level but the use of unreliable TDM
and other rotating heated arm modulators limited the practical
application of the method. In the present report, we revisited the
coupling using the jet-cooled loop modulator for the measurement
of ultra-trace levels of PCDD/Fs in human serum samples by means
of cryogenic zone compression (CZC) GC–IDHRMS. We did not use
a different stationary phase and secondary oven for the second
dimension separation as in true GC×GC, we could have done so,
andwe chose rather to simplify the experiments by just incorporat-
ing modulated cryofocusing on the same columns to concentrate
the analytes and lower the detection limits.
2. Experimental
2.1. Standards and samples
Dioxin standards were from Cambridge Isotope Laboratories
(Andover, MA, USA) and were diluted with nonane to the fol-
lowing concentrations (in fg/L) of 2,3,7,8-tetrachlorodibenzo-p-
dioxin (2,3,7,8-TCDD) and 1,2,3,7,8-pentachlorodibenzo-p-dioxin
(1,2,3,7,8-PeCDD): 20, 10, 5, 2.5, 1.25, 0.625, 0.313, 0.157. Standards
of 2,2-bis (4-chlorophenyl-1,1,1-trichloroethane) (DDE, a metabo-
lite of DDT) and 2,2′,4,4′,5,5′-hexabromobiphenyl (BB-153) were
obtained from Cambridge Isotope Laboratories.
Serum samples were multiple aliquots of National Institute
of Standards and Technology Standard Reference Material 1589a
(NIST SRM 1589a; PCBs, Pesticides, and Dioxins/Furans in Human
Serum, August 9, 2000). The sample preparation method has been
described previously [26]. Briefly, serum samples were mixed with
internal standards for 30min. One volume of formic acid and one
volume of water were added and the mixture was gently swirled.
The solid-phase extraction (SPE) cartridges were conditioned with
two volumes of methanol and two volumes of water. The sample
mixture was then added through the activated SPE cartridges at
5mL/min. One volume of water was then added to the cartridge
before pumping to dryness at 10psi for one hour. The elution of
the SPE cartridges was carried out using three volumes of hex-
ane. The extracts were further cleaned-up and fractionated using
an automated strategy [27]. It consisted in low pressure liquid
chromatography based on acidic silica, basic alumina, and carbon
dispersed on Celite. The dioxin fraction resulted from the elution
of the carbon column by 50mL of toluene. It was concentrated and
solvent exchanged to nonane, with a final volume of 5L.
Samples prepared from 10g aliquots of NIST SRM 1589a were
reconstituted in 20l of nonane and diluted to the follow-
ing approximate concentrations (based on NIST reference values
corrected assuming 70% recovery for the sample preparation pro-
cedure) of 2,3,7,8-TCDD (in fg/L): 6.50, 1.63, 1.30, 1.10, 0.81, 0.65,
0.54, 0.41, 0.33, 0.21, 0.16. Subsequent experiments samples were
prepared from aliquots of NIST SRM 1589a, ranging from 1 to 5g
and reconstituted in 5 or 10L of nonane.
2.2. CZC-GC–IDHRMS and GC–IDHRMS analysis
For CZC-GC–IDHRMS, the gas chromatographwas a 6890N (Agi-
lent Technologies, Palo Alto, CA, USA) operated in splitless mode
and the mass spectrometer was a MAT95XP (ThermoElectron,
Bremen, Germany). For CZC-GC, the column used for dioxin mea-
surement was a DB-5 (Agilent, 7m×0.1mm i.d.×0.1m df) and
formeasurement of DDE andBB-153, aDB-5 (Agilent, 5m×0.1mm
i.d.×0.1mdf)was employed. Themodulationdevicewas the loop
modulator from Zoex Corporation (Houston, TX, USA) which uti-
lizes liquid nitrogen as the cryogen and consists of one cold jet
and one hot jet with 2 loops of column passing through the jets,
effectively creating a quadruple jet or dual-stage system [23]. The
modulator was positioned approximately 75 cm from the exit end
of the column. The modulation period for the maximum sensitivity
enhancement was either 6 or 9 s for dioxins and 5 s for DDE and
BB-153, and the hot jet pulse time was 800ms for dioxin, 600ms
for DDE and BB-153. For resolution of all congeners of a given class,
faster modulation cycles were employed.
Conventional GC–HRMS was performed using a Thermo-
MAT95XP or DFS and a 6890N GC using a HT-5 (SGE, 30m×0.25m
i.d.×0.1m df) for BB-153 or a DB5-MS (Agilent, 30m×0.25m
i.d.×0.25m df) for 2,3,7,8-TCDD or DDE, under conditions
described previously [28].
Mass spectrometry was performed in electron ionization (EI)
modeat 10,000 resolutionusing selected ionmonitoring (SIM)with
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one multiple ion detection (MID) group per congener class. Cycle
times ranged from40 to70ms (14 to25Hz). The ion source temper-
aturewas270 ◦C, trap currentwas0.65mAandelectron energywas
40eV. Data analysis and visualization was performed using Ther-
moElectron XCalibur and GC Image software. Quantification was
performed using GC Image software (Lincoln, Nebraska, USA).
3. Results and discussion
3.1. Optimization of CZC-GC–IDHRMS parameters
Since the peaks resulting from GC×GC using cryogenic mod-
ulation are extremely narrow, and the data acquisition on the
double-focusing magnetic sector mass spectrometer is much
slower than detection methods typically used with the GC×GC
technique, a number of adjustments had to bemade to couple these
two very sensitive techniques. No secondary oven was used, which
meant that the peaks, while still very narrow, were wider than
those often seen when GC×GC is used with more typical detec-
tors. Another feature that distinguishes the work described in this
paper from the typical approach toGC×GC is that in thiswork, only
one column was used and the modulation was performed near the
end of the analytical column. Such a system lacks the orthogonality
typically deemed necessary for GC×GC, but even with this one-
column only system a slight improvement of the separation in the
‘second dimension (2D)’ is observed, most probably to be related to
the decreased peak width.
For sensitivity enhancement by GC with thermal modulation,
the largest increase is obtained when the entire peak of interest
is trapped and remobilized in one event or “slice”. For this rea-
son relatively long modulation times were used. Although such an
approachendangered the respectof the conservation rulebypoten-
tially re-combining species chromatographically separated prior to
modulation, it optimizes the signal enhancement effect. Addition-
ally, the use of HRMS can, in most cases of coelution, selectively
differentiate between target analytes and co-eluters. GC separation
conditions have, nevertheless, to be carefully studied to avoid sit-
uations where isobaric species could closely elute and potentially
pollute mass spectra and quantification.
Because of the lack of orthogonality, and because of the remobi-
lization in one event or “slice”, it appeared to be more appropriate
to report the technique in terms of cryogenic zone compression
(CZC) rather than true GC×GC.
Peak widths under the conditions used were typically in the
300–400ms range when measured at peak base (200–250ms at
half-height). Based on the accepted minimum need of at least
seven data points across the GC peak for proper description of the
Gaussian shape [29], the acquisition rate of the slow scanning sec-
tor MS instrument had to be sped up. This was quite a challenge
knowing that the classical acquisition rate for the magnetic sector
GC–IDHRMS approach is around one Hz (cycle time of approx-
imately 1000ms, see Table 1). Basic MS parameters were thus
optimized to reach acquisition rates of up to 20Hz (7 data points
across a 350ms peak width, cycle time of approximately 45ms, see
Table 1), while maintaining the required high mass resolution.
Table 1
Selected ion monitoring (SIM) descriptor for GC–IDHRMS and CZC-GC–IDHRMS.
TCDD window GC–IDHRMS CZC-GC–IDHRMS
Number of monitored ions 15 3
Target dwell time (ms) 15–100 10
Lock mass dwell time (ms) 50 2
Electric jump time (ms) 10 6
Cycle time (ms) 1100 44
Scan rate ∼1Hz ∼20Hz
For classical routineHRMSdioxinmethodswhere several chlori-
nation levels canbemonitored in a sameSIMwindow, andwhere at
least two ions are followed for both native analytes and isotopically
labeledanalytes, it is commontomonitorup to15different ions. For
CZC-GC–IDHRMS, the mass spectrometer method was constructed
in such a way that each analyte or congener class was monitored in
a separate group in the SIM descriptor. Also, only one ion was mon-
itored for each of the 13C-labeled internal standards so that longer
dwell times were available to monitor the targeted native ions.
These two major modifications allowed target dwell time values
of 10ms instead of classically 15–100ms (Table 1).
Some additional adjustments to the mass spectrometric param-
eters were necessary to optimize the conditions. For example, the
lock and calibration masses were only monitored once every 50
cycles, and the dwell times on the lock and calibrationmasseswere
set to the minimum possible value of 2ms. Although the loss of
the lock mass can easily be a major issue during HRMS analysis of
dioxin, especially for challenging matrices, no noticeable increase
in lock mass loss frequency was recorded, due to the very short
time spent to measure it, even for analysis of real serum samples.
Also, the time allowed for the electric jumps between ions within
the MID group was reduced from the default time of 10ms to a
time of 6ms, which appeared to be long enough to ensure proper
performance. This demonstrated the ruggedness of the MS sector
instrument in terms of noise management and stability of even
extremely set parameters. The optimization of the sector instru-
ment parameters resulted in cycle times of 44ms, which resulted
in scan rates higher than20Hz. These featuresmaximized thedwell
times to achieve maximum sensitivity for the native ions under the
rapid scanning conditions that were required for the CZC experi-
ments.
3.2. CZC-GC–IDHRMS of PCDDs in standards and serum samples
When performing human biomonitoring for dioxin and dioxin-
like compounds, it is extremely common to work on very limited
specimen sizes, e.g. a few mL of blood. Combined with the fact
that human levels are decreasing in industrialized societies, levels
below the ultra-trace range are often targeted for many congeners.
This is especially thecase for themost toxic (TEFs =1) congeners like
2,3,7,8-TCDD and 1,2,3,7,8-PeCDD [30], which are often reported
as non-detected. Because of this, the decision was made to initially
concentrate efforts on sensitivity enhancement for 2,3,7,8-TCDD
and 1,2,3,7,8-PeCDD, although other congeners were also moni-
tored.
Optimization of the method for sensitivity enhancement of
these two congeners resulted in the ability to detect low attogram
(ag) amounts of these compounds. Fig. 1 shows the chromatogram
resulting from an injection of a standard of 1 fg of native 2,3,7,8-
TCDD (S/N=1420:1) for the M+2 ion of m/z=321.8936amu. When
the system operates at maximal sensitivity, i.e. clean ion source
and relatively new GC column, standards lower than 1 fg can
be detected under these conditions. For example, approximately
313ag of 2,3,7,8-TCDD (Fig. 2) gives a S/N of 400:1 (4 sigma). This
had not yet been reported using classical GC–IDHRMS. A similar
sensitivity enhancement was observed for 1,2,3,7,8-PeCDD (not
shown).
Careful dilutions of the lowest concentrations of commercially
available 2,3,7,8-TCDD standards created a calibration standard set
that was used to assess the linearity of the measured peak volume
of the m/z 321.8936 ion versus concentration. An acceptable linear
responsewas obtained (R2 =0.9859) for a 1L injection of the stan-
dardsovera rangeof313ag/L to20,000ag/L.An isotope-dilution
calibration curve was also constructed using the 13C12-2,3,7,8-
TCDD as the internal standard over the range of 500ag/L to
35,000ag/L. Triplicate measurements produced a good corre-
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Fig. 1. CZC-GC–IDHRMS measurement of a 2,3,7,8-TCDD standard, only one mass
monitored m/z 321.8936 [M+2], 1 fg on column, S/N=1420:1 (4 sigma).
lation (R2 =0.9953) over this large dynamic range (the relative
response factor (RRF) for this curve was 1.75), although varia-
tion coefficients were up to 50% for the lowest calibration points.
This limited precision at the low end can partially be attributed
to the large difference in concentration between the native and
the labeled 2,3,7,8-TCDD (concentration ratio =0.002). This can be
solvedby creating special ‘ultra-plus trace’ standardmixtures capa-
ble of covering 2–3 orders of magnitude. Such solutions should
be prepared in close collaboration with producers of standards to
ensure ultra high purities of labeled solutions and accurate prepa-
ration of solutions.
As a next step, to determine theutility of theGC×GCmethod for
real measurement of PCDDs in serum samples, we used a standard
human reference serum-matrix NIST SRM 1589a, which contained
only natural levels of dioxins [31]. The major goal was to esti-
mate the potential effect of the serum matrix on the modulated
signal in terms of detection limits. Initial experiments with serum
samples used the same sample sizes (10g) that are normally used
for routine GC–HRMS analyses. The serum was prepared using a
published extraction and cleanup procedure [26], concentrated to
20L and further diluted to concentration levels similar to those
analyzed in standards. Fig. 3 shows a total ion chromatogram of
the tetra- through octa-PCDD congeners. In this figure, it can be
seen that a second separation on the 2D-section of column seems
to occur as a result of the modulation and the reduction of peak
width. Experiments on sample extracts from human serum NIST
SRM 1589a which were diluted after preparation, also resulted in
very low limits of detection. The matrix, expected to be problem-
Fig. 2. CZC-GC–IDHRMS measurement of 2,3,7,8-TCDD showing the signal at m/z
321.8936 resulting from an injection of a standard containing 313ag, S/N 400:1 (4
sigma).
atic at the long modulation periods used, was not found to be an
issue, as illustrated in Fig. 4 for 540ag of 2,3,7,8-TCDD (the same
is true for other congeners, not shown). As an example, on-column
injection of a serum extract containing 223ag of 1,2,3,7,8-PeCDD
(70% recovery rate assumed) resulted in a peak with a S/N of 188:1
(4 sigma, m/z=355.8546).
3.3. Comparison of GC–IDHRMS and CZC-GC–IDHRMS
In order to minimize variations due to instrumental setup, the
same MAT95XP HRMS instrument was equipped with two Agilent
6890N gas chromatographs utilizing the dual GC inlet capability
of the instrument. One of the GC ovens was equipped for classical
1D GC, the other GC oven was equipped for GC×GC. We measured
2,3,7,8-TCDD in a diluted extract of SRM 1589a using both the con-
Fig. 3. CZC-GC–IDHRMS 3D plot showing the total ion current (TIC) resulting from
an injection of NIST SRM human serum extract in which seven 2,3,7,8-substituted
dioxin congeners (2 unresolved) and one 2,3,7,8-substituted furan congener were
monitored.
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Fig. 4. Plots showing signal at m/z 319.8965 (a) and 321.8936 (b) of 2,3,7,8-TCDD
resulting from a CZC-GC–IDHRMS injection of NIST SRM 1589a. The human serum
extract is equivalent to approximately 540ag, assuming 70% recovery.
ventional GC–IDHRMS and the CZC-GC–IDHRMS techniques with
the conditions described in Section 2.
One L of the diluted human serum extract (∼4 fg of 2,3,7,8-
TCDD) was first injected into the single dimensional GC column
and measured by HRMS. Following the measurement, another one
L was injected into the CZC column set and measured by HRMS.
The results of the two injections are shown in Fig. 5. The con-
ventional GC–IDHRMS was unable to measure 2,3,7,8-TCDD in the
extract while the CZC-GC–IDHRMS approach gave a peak with a
S/N of 600:1 for 2,3,7,8-TCDD. The advantage of the CZC approach
can also be seen by comparing the peak height measurement of
the 13C12-2,3,7,8-TCDD internal standard which was an order of
magnitude larger using the CZC-GC–HRMS approach (Fig. 5). The
large increase in the S/N ratio is due to the focusing effect of the
modulation process which refocuses and sharpens the peak.
Subsequent experiments were conducted on smaller sized
samples of NIST SRM1589a (1–5g) prepared using the sameprepa-
ration method usually used for larger samples [26]. In this case the
signal resulting from 2,3,7,8-TCDD could still be observed, but the
sample matrix was found to be much more problematic under the
conditions used. In sample sizes below 4g the matrix effect posed
a significant problem. The high signal resulting from the matrix
was observed in hexane blanks as well as serum samples and thus
was deemed to arise from the sample preparation procedure itself.
Attempts tocircumvent thematrixproblembydecreasing themod-
ulation period and lengthening the portion of column used as the
2D column have been only partly successful, and more work will
be necessary to optimize this system for analysis of PCDDs in small
serum samples. The small samples resulted in a high level of noise
associated with the matrix even when injected on a conventional
GC–HRMS system. A more comprehensive GC×GC system with a
different 2D column may be helpful, but it is also expected that
modifications to the sample preparation method will need to be
made, since the majority of the matrix effect observed is seen in
thehexaneblanks aswell as in the serumsamples. Theminiaturiza-
tion of theprocedure because of the scaling downof the sample size
appears to be a key step in the CZC-GC–IDHRMS approach. Reduc-
tion of the sample clean-up and fractionation columns has already
been successfully reported [27] and could be used in conjunction
with recently reported miniaturized pressurized liquid extraction
(PLE) [32]. It is interesting to emphasize that even with a lowering
of the matrix-solvent noise, it is clear that measuring at such low
levels will be extremely dependent of the blank levels. As it was
already foreseen by Ferrario et al. more than 10 years ago [33], the
establishment of the method LODs will now be limited by the labo-
ratory environment rather than by the instrument sensitivity itself.
This background contamination potentially poses a serious prob-
lem in terms of defining the limit of detection and quantification
above background that can be reliably detected for various samples
matrices.
3.4. CZC-GC–IDHRMS of DDE and BB-153 in standards and
human dried-blood spot (DBS) samples
In view of the interest in the ability to detect environmen-
tal contaminants in smaller sample sizes, it was decided to apply
the CZC-GC–IDHRMS technique to the measurement of contami-
nants of interest in human DBS specimens. A report on the analysis
of dried-blood spot specimens using GC with electron-capture
detection has been published earlier [34] and we have included
preliminary data here using CZC-GC–IDHRMS to show the utility of
the GC×GC technique for small sample sizes. A CZC method was
developed (to be reported separately) to analyze standards and
blood spot samples for DDE and BB153. Again, results with stan-
dardswere very impressive, showing considerable enhancement in
sensitivity over that observed using the conventional GC–IDHRMS
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Fig. 5. A comparison of the conventional GC–IDHRMS (1 MID of 14 ions) measurement of 2,3,7,8-TCDD in a human serum sample diluted extract with a CZC-GC–IDHRMS (1
MIDof2 ions)measurementof the sameextract. Theupperpart corresponds to thenative 12C12-2,3,7,8-TCDDand the lowerpart corresponds to the labeled 13C12-2,3,7,8-TCDD.
technique. For example, injection of a standard containing 200 fg
of BB153 resulted in a S/N of 5,027:1 for the signal at m/z 546.6189
ion, corresponding to the loss of one 81Br atom from theM+6parent
ion at m/z 627.5352.
Application of the CZC-GC–IDHRMS technique to human DBS
samples resulted in far less difficulty with matrix effects than was
observed with the PCDDs in serum. The technique was first applied
to analysis of spiked DBS samples and then to analysis of actual
unknown specimens (results to be reported separately). In both
cases the sampleswere analyzedby conventionalGC–HRMSaswell
as by CZC-GC–IDHRMS. The CZC-GC–IDHRMS method was very
rapid, analyzing samples for both BB-153 and DDE and the exter-
nal standard, 13C6-1,2,3,4-TCDD in about six minutes. The results
from theCZC techniquewithDBS specimens also showedenhanced
sensitivity when compared with the Thermo Electron DFS HRMS,
which is three to five times more sensitive than the MAT95XP [35].
Fig. 6 shows a comparison of the same unspiked blood spot sam-
ple extract analyzed byGC–IDHRMS (DFS) and by CZC-GC–IDHRMS
using the MAT95. The sensitivity enhancement for measuring DDE
using the CZC system is evident by comparing the S/N ratios for
DDE in Fig. 6.
3.5. Challenges in performing analyses at sub-ultra-trace levels
During these experiments, we observed significant ion ratio
skewing for the low end of the working range. The most likely
explanation for this is that very few ions actually reach the detec-
torwhenworking at the attogram level. Therefore, one can imagine
that the ion statistics cause the measured isotopic ratio to fail nor-
mal QA/QC threshold of ±20% from theoretical values. Considering
an average human serum sample of 0.5% lipidswith a level of 1pg/g
lipids for 2,3,7,8-TCDD. A sample size of 2 gwould represent 10 fg of
2,3,7,8-TCDD, or approximately 2×107 molecules of 2,3,7,8-TCDD.
Taking into account a recovery rate of 50% and the splitless injec-
tion of 1L from 5L, this corresponds to 2×106 molecules that
are entering the GC–MS system. This can be extrapolated to what
actually enters the ion source of theMS instrument. Ifwe consider a
1% ionization efficiency, a 50% survival of the parent ion after frag-
mentations, a 10% overall transmittance into the mass analyser,
5 acquisition cycles per peak, and 10ms dwell time every 40ms,
the number drops to less than 50 molecules of TCDD available
at the detector for ion ratio calculations. Such a limited number
of molecules could probably be a limitation to allow proper ion
statistics to take place.
Investigations on the lock mass dwell time minimum require-
ments and influence on mass accuracy were also carried out
because interferences could also be due to partial minimal
coelution with other analytes that could be much higher in con-
centration. As an example, one needs a resolution of at least 8000
to differentiate between 12C-2,3,7,8-TCDD and 13C-2,3,7,8-TCDF
(Table 2). Although the interfering ions from 13C-2,3,7,8-TCDF are
less abundant isotopically, their concentrations are two orders
of magnitude higher, which makes them from 100 to 650 times
more intense than 12C-2,3,7,8-TCDD ions. A similar, and chromato-
graphically as relevant, situation is present with PCB-126. Further
research is needed to ensure proper understanding of those low
end deviations and to solve this issue.
4. Summary and conclusions
The use of a GC×GC loop modulator to perform CZC-GC cou-
pledwith IDHRMShas been shown to be themost sensitivemethod
available for the measurement of certain environmental contam-
inants in human samples. In the current study, the sensitivity
enhancement alone has been considered; no advantage has even
yet been taken from the second dimension separation power. The
preliminary data onblood spots are promising andopen those sam-
ples to environmental contaminants analyses like never before.
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Fig. 6. Measurement of DDE from an unspiked dried-blood spot (BDS) sample using (a) the GC–IDHRMS (DFS instrument) system and (b) the CZC-GC–IDHRMS (MAT95
instrument) system. For GC–IDHRMS, the parent ions of DDE could not be used because of interferences due to close eluting PCBs and OCPs. Because of this, one had to use
[M−35Cl2] for DDE, to avoid interferences in the DDE parent ion by other masses. Therefore, ions at m/z 246.0003 and m/z 247.9975 were monitored for the native signals,
and ions at m/z 258.0404 and m/z 260.0374 (not shown) were monitored for the label signals. For CZC-GC–IDHRMS, DDE was recorded alone and parent ions were recorded.
Therefore, ions at m/z 315.9380 and m/z 317.9351 were monitored for the native signals, and ions at m/z 327.9782 and m/z 329.9752 (not shown) were monitored for the
label signals.
Table 3 lists the sensitivity for 2,3,7,8-TCDD using various GC
and mass spectrometry combinations. Further development and
application of this technique, especially to the analysis of human
dried-blood spot samples, could yield unprecedented sensitivity
for rapid and routine screening of human specimens for the pres-
ence of environmental contaminants. Table 4 depicts the current
state-of-the-art in being able to measure approximately 586,000
2,3,7,8-TCDD molecules.
The use of the CZC-GC technique with a newer, more sensi-
tive mass spectrometer, such as the Thermo Electron DFS, would
further enhance the sensitivity of this approach. However, a strat-
egy has to be proposed to ensure miniaturization of the sample
Table 2
Resolution required to separate the M+4 and M+6 ions for the 13C-2,3,7,8-TCDF internal standard from the M and M+2 ions for 12C-2,3,7,8-TCDD.
Specie Mass Required resolution Ion in cluster Isotope abundance Level (pg/l) Specie ratio
12C-2,3,7,8-TCDD 321,8930
>8000
M+2 100% 0.05 1
13C-2,3,7,8-TCDF 321,9325 M+6 10% 50 100
12C-2,3,7,8-TCDD 319,8960
>8000
M 75% 0.05 1
13C-2,3,7,8-TCDF 319,9354 M+4 50% 50 650
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Table 3
Analytical sensitivity for 2,3,7,8-TCDD using various GC–MS approaches.
Technique Sample Amount on column S/N (4 sigma)
GC (MAT95XP)–HRMS Standard 20 fg 43
GC (DFS)–HRMS Standard 20 fg 604
CZC-GC (MAT95XP)–HRMS Standard 313ag 400
CZC-GC (MAT95XP)–HRMS Serum 325ag 161
GC×GC-LRTOFMS Standard 500 fg 6
Table 4
Current state-of-the-art for the measurement of 2,3,7,8-TCDD and the potential detection limits and numbers of molecules (calculations based on M+2 321.8936 m/z ion).
Quantity Notation Number of moles Number of molecules
1 nanogram (ng) or 10−9 g ppb 3.1×10−12 (3,1 picomoles) 1,870,000,000,000 (1.87×1012)
1 picogram (pg) or 10−12 g ppt 3.1×10−15 (3,1 femtomoles) 1,870,000,000 (1.87×109)
1 femtogram (fg) or 10−15 g ppq 3.1×10−18 (3,1 attomoles) 1,870,000 (1.87×106)
313 attogram (ag) or 10−18 g ppquint 9.7×10−19 (972 zeptomoles) 586,000 (5.86×105)
1 attogram (ag) or 10−18 g ppquint 3.1×10−21 (3,1 zeptomoles) 1,870 (1.87×103)
1 zeptogram (zg) or 10−21 g ppsext 3.1×10−24 (3,1 yoctomoles) 1,87
1 yoktogram (yg) or 10−24 g ppsept 3.1×10−27 (3,1 ‘phantomoles’) <1
Bold is current state-of-the-art.
preparation procedure, and proper monitoring and control of the
laboratory environment in terms of blanks. Once such a complete
method would be available, it would be extremely valuable for
considering biomonitoring studies in which baby and child are tar-
geted. DBS samples taken at early stages of life could systematically
be screened for major toxicants or stored until particular health
problem would appear at the adult stage, to try to link particular
pathology to exposures that occurred years earlier.
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